Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII-Reference-Cited by-同舟云学术

Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII

Published:2007-06 Issue:3 Volume:83 Page:326-332
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Aerts Hugo J.W.L.,Dubois Ludwig,Hackeng Tilman M.,Straathof Roel,Chiu Roland K.,Lieuwes Natasja G.,Jutten Barry,Weppler Sherry A.,Lammering Guido,Wouters Bradly G.,Lambin Philippe

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference29 articles.

1. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas;Akimoto;Clin Cancer Res,1999

2. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer;Baselga;J Clin Oncol,2005

3. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

4. Quantitative PET of EGFR expression in xenograft-bearing mice using (64)Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody;Cai;Eur J Nucl Med Mol Imaging,2007

5. Strategy for the synthesis of multivalent peptide-based nonsymmetric dendrimers by native chemical ligation;Dirksen;Chemical communications (Cambridge, England),2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments;Theranostics;2019

2. MALDI-MSI of Immunotherapy: Mapping the EGFR-Targeting Antibody Cetuximab in 3D Colon-Cancer Cell Cultures;Analytical Chemistry;2018-11-27

3. PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer;Radiotherapy and Oncology;2017-02

4. Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach;Oncotarget;2016-12-11

5. Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design;Scientific Reports;2016-05-05